These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6571377

  • 1. [Type A adenocarcinoma grafted into C3H/he-M mice subjected to treatment with various antineoplastic agents. I. Biological study].
    Flores JM, Gallego E, Castaño M, Gallego A.
    Rev Esp Oncol; 1983; 30(3):337-59. PubMed ID: 6571377
    [Abstract] [Full Text] [Related]

  • 2. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study].
    Flores JM, Gallego E, Castaño M, González JL.
    Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378
    [Abstract] [Full Text] [Related]

  • 3. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F, Zaccheo T, Casazza AM, Bellini O, Di Marco A.
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract] [Full Text] [Related]

  • 4. Can neo-adjuvant chemotherapy prevent residual tumors?
    Bourut C, Chenu E, Mathé G.
    Suppl J Med Oncol Tumor Pharmacother; 1988 Nov; 1():59-63. PubMed ID: 2977811
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY, Ma KS, Guan JF.
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4619-26. PubMed ID: 14555538
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.
    Penhaligon M, Camplejohn RS.
    J Natl Cancer Inst; 1985 Apr 01; 74(4):869-73. PubMed ID: 3857381
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM, Joseph WR, Baguley BC.
    Anticancer Res; 1993 Apr 01; 13(4):1139-41. PubMed ID: 8352536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W.
    Strahlenther Onkol; 1991 Sep 01; 167(9):553-60. PubMed ID: 1925940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of hydroxyurea on growth of a transplantable mouse mammary adenocarcinoma.
    Lerner LJ, Bianchi A, Dzelzkalns M.
    Cancer Res; 1966 Nov 01; 26(11):2297-300. PubMed ID: 5956633
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.